BACKGROUND AND PURPOSE: We investigated changes in oxidative damage after ischemic stroke using multiple biomarkers. METHODS: Serial blood and urine samples of ischemic stroke subjects and age-matched control subjects were assayed for F₂-isoprostanes, hydroxyeicosatetraenoic acid products, F₄-neuroprostanes, 24-hydroxycholesterol, allantoin, and urate. RESULTS: Sixty-six stroke subjects (mean age, 65 years; median National Institutes of Health Stroke Scale 17) and 132 control subjects were recruited. A bimodal pattern of change was observed in plasma and urinary F₂-isoprostanes and plasma 24-hydroxycholesterol. The rise in plasma hydroxyeicosatetraenoic acid products, F₄-neuroprostanes, and allantoin was highest 6 to 12 hours after stroke onset, whereas plasma urate was significantly lower than controls on Days 1 to 3. After adjusting for age and baseline National Institutes of Health Stroke Scale, baseline plasma esterified hydroxyeicosatetraenoic acid products (OR, 1.01; 95% CI, 1.01 to 1.02), plasma urate (1.01; 1.00 to 1.01), and plasma free F₄-neuroprostanes (2.73; 1.76 to 3.93) were associated with 90-day good functional recovery (modified Rankin Scale ≤1). CONCLUSIONS: Multiple markers of oxidative damage are increased immediately after stroke and remain elevated for several days. Recognition of these temporal changes may help design better antioxidant treatment trials for acute ischemic stroke.
BACKGROUND AND PURPOSE: We investigated changes in oxidative damage after ischemic stroke using multiple biomarkers. METHODS: Serial blood and urine samples of ischemic stroke subjects and age-matched control subjects were assayed for F₂-isoprostanes, hydroxyeicosatetraenoic acid products, F₄-neuroprostanes, 24-hydroxycholesterol, allantoin, and urate. RESULTS: Sixty-six stroke subjects (mean age, 65 years; median National Institutes of Health Stroke Scale 17) and 132 control subjects were recruited. A bimodal pattern of change was observed in plasma and urinary F₂-isoprostanes and plasma 24-hydroxycholesterol. The rise in plasma hydroxyeicosatetraenoic acid products, F₄-neuroprostanes, and allantoin was highest 6 to 12 hours after stroke onset, whereas plasma urate was significantly lower than controls on Days 1 to 3. After adjusting for age and baseline National Institutes of Health Stroke Scale, baseline plasma esterified hydroxyeicosatetraenoic acid products (OR, 1.01; 95% CI, 1.01 to 1.02), plasma urate (1.01; 1.00 to 1.01), and plasma free F₄-neuroprostanes (2.73; 1.76 to 3.93) were associated with 90-day good functional recovery (modified Rankin Scale ≤1). CONCLUSIONS: Multiple markers of oxidative damage are increased immediately after stroke and remain elevated for several days. Recognition of these temporal changes may help design better antioxidant treatment trials for acute ischemic stroke.
Authors: Ijeoma Esiaba; Danilyn M Angeles; Megan S Holden; John B C Tan; Yayesh Asmerom; Gerald Gollin; Danilo S Boskovic Journal: Transl Stroke Res Date: 2015-05-22 Impact factor: 6.829
Authors: Ge Li; Steven P Millard; Elaine R Peskind; Jing Zhang; Chang-En Yu; James B Leverenz; Cynthia Mayer; Jane S Shofer; Murray A Raskind; Joseph F Quinn; Douglas R Galasko; Thomas J Montine Journal: JAMA Neurol Date: 2014-06 Impact factor: 18.302
Authors: Anatoly Samoylenko; Jubayer Al Hossain; Daniela Mennerich; Sakari Kellokumpu; Jukka Kalervo Hiltunen; Thomas Kietzmann Journal: Antioxid Redox Signal Date: 2013-04-15 Impact factor: 8.401
Authors: Svetlana Lorenzano; Natalia S Rost; Muhib Khan; Hua Li; Fabricio O Lima; Matthew B Maas; Rebecca E Green; Tijy K Thankachan; Allison J Dipietro; Ken Arai; Angel T Som; Loc-Duyen D Pham; Ona Wu; Gordon J Harris; Eng H Lo; Jeffrey B Blumberg; Paul E Milbury; Steven K Feske; Karen L Furie Journal: Stroke Date: 2018-01-25 Impact factor: 7.914
Authors: Isabella Canavero; Helene A Sherburne; Sarah M Tremble; Wayne M Clark; Marilyn J Cipolla Journal: Transl Stroke Res Date: 2016-01-26 Impact factor: 6.829
Authors: Rufus Turner; Stephen O Brennan; Louisa V Ashby; Nina Dickerhof; Melanie R Hamzah; John F Pearson; Lisa K Stamp; Anthony J Kettle Journal: J Biol Chem Date: 2018-11-01 Impact factor: 5.157
Authors: Kazim Yigitkanli; Anton Pekcec; Hulya Karatas; Stefanie Pallast; Emiri Mandeville; Netra Joshi; Natalya Smirnova; Irina Gazaryan; Rajiv R Ratan; Joseph L Witztum; Joan Montaner; Theodore R Holman; Eng H Lo; Klaus van Leyen Journal: Ann Neurol Date: 2012-11-28 Impact factor: 10.422